Mentor: Ronald Weigel, MD, PhD, MBA

Thesis:

SUMOylated Etv1 Establishes Cancer Stem Cells that Support Non-stem Cancer Cells Tumorigenesis

Presentations:

2024 Holden Comprehensive Cancer Center Retreat. SUMO conjugated Etv1 is required for Neu-driven mammary oncogenesis. (poster)

2024 Oral Presentation, AACR Annual Meeting "The Influence of SUMOylation on Transcriptional Regulation by EtV1 in Breast Cancer

Award:

2022 Post-Comprehensive Fellowship

Publication:

Li Z, Koch KE, Thompson DT, Van der Heide DM, Chang J, Franke CM, et al. Sumoylated Etv1 establishes mouse mammary cancer stem cells that support tumorigenesis by non-stem cancer cells. Dev Cell. 2025;60(17):2264-78.e7.